Famotidine Dosage and Duration
For duodenal ulcer, use famotidine 40 mg once daily at bedtime for 4 weeks, with most patients healing by this time; if unhealed, extend treatment for an additional 2-4 weeks up to a maximum of 8 weeks total. 1
Duodenal Ulcer Treatment
The FDA-approved regimen is straightforward 1:
- Standard dose: 40 mg once daily at bedtime OR 20 mg twice daily
- Duration: Up to 8 weeks
- Clinical reality: 70% of patients heal by week 4, and 83% by week 8 1, 2
For patients not healed after 4 weeks, continue treatment for an additional 2-4 weeks rather than abandoning therapy 1. The once-daily bedtime dosing (40 mg) is preferred for convenience and has equivalent efficacy to twice-daily regimens 2.
Gastric Ulcer Treatment
Use famotidine 40 mg once daily at bedtime for up to 8 weeks 1:
- Most patients heal within 6 weeks (66-78% healing rate)
- Continue to 8 weeks if needed
- No evidence supports treatment beyond 8 weeks 1
GERD Treatment
The approach differs based on disease severity:
Non-Erosive GERD (Symptomatic)
Use famotidine 20 mg twice daily for up to 6 weeks 1. This is a Grade B recommendation with fair evidence 3. However, recognize that PPIs are more effective than H2-receptor antagonists for GERD 3. Famotidine is reasonable when:
- PPIs are contraindicated or not tolerated
- Cost is a major concern
- Rapid onset of action is needed for on-demand therapy 3
Erosive Esophagitis
Use famotidine 40 mg twice daily for up to 12 weeks 1, 4:
- The 40 mg twice daily regimen is superior to 20 mg twice daily (69% vs 54% healing at 12 weeks) 4
- Alternative: 20 mg twice daily is acceptable but less effective 1
- Critical caveat: PPIs remain the first-line treatment for erosive esophagitis with Grade A evidence 3
Maintenance Therapy for Duodenal Ulcer Recurrence Prevention
Use famotidine 20 mg once daily for up to 1 year 1. This is only indicated after successful healing of the initial ulcer.
Renal Impairment Adjustments
Dosage reduction is mandatory for creatinine clearance <60 mL/min 1:
Moderate impairment (CrCl 30-60 mL/min):
- Duodenal/gastric ulcer: 20 mg once daily OR 40 mg every other day
- GERD: 20 mg once daily
- Erosive esophagitis: 20 mg once daily OR 40 mg every other day
Severe impairment (CrCl <30 mL/min):
- All indications: 20 mg every other day (or 10 mg once daily using alternate formulation)
Key Clinical Pitfalls
Don't exceed recommended durations: Trials have not established safety beyond 8 weeks for ulcers, 6 weeks for non-erosive GERD, or 12 weeks for erosive esophagitis 1
Recognize famotidine's limitations: While effective, famotidine is inferior to PPIs for GERD syndromes with Grade A evidence 3. Consider it a second-line option when PPIs fail, are contraindicated, or for cost reasons.
Don't use higher doses: No evidence supports doses exceeding standard recommendations 3
Timing matters: Take once-daily doses at bedtime; twice-daily doses in morning and at bedtime 1
Renal function monitoring: Always check creatinine clearance before prescribing, as dose adjustments are common and necessary 1